AGC
Aspen Grove Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Buy |
25,844
+150
| +0.6% | +$13.2K | 0.39% | 40 |
|
|
2025
Q1 | $2.34M | Hold |
25,694
| – | – | 0.45% | 38 |
|
|
2024
Q4 | $2.22M | Buy |
25,694
+233
| +0.9% | +$20.1K | 0.47% | 37 |
|
|
2024
Q3 | $2.42M | Buy |
25,461
+100
| +0.4% | +$9.5K | 0.53% | 33 |
|
|
2024
Q2 | $2.32M | Buy |
25,361
+151
| +0.6% | +$13.8K | 0.55% | 32 |
|
|
2024
Q1 | $2.29M | Sell |
25,210
-1
| -0% | -$91 | 0.65% | 29 |
|
|
2023
Q4 | $2.05M | Buy |
25,211
+204
| +0.8% | +$16.6K | 0.62% | 32 |
|
|
2023
Q3 | $2M | Buy |
25,007
+126
| +0.5% | +$10.1K | 0.74% | 31 |
|
|
2023
Q2 | $1.96M | Buy |
24,881
+208
| +0.8% | +$16.4K | 0.63% | 31 |
|
|
2023
Q1 | $1.92M | Hold |
24,673
| – | – | 0.84% | 27 |
|
|
2022
Q4 | $1.92M | Buy |
+24,673
| New | +$1.92M | 0.89% | 27 |
|